Mineralys Eyes NDA As Lorundrostat Scores CKD Win In Race With AstraZeneca

Mineralys Is In A Close Race With AstraZeneca

Mineralys Therapeutics
Mineralys Therapeutics (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from Therapy Areas